Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer. Read more about Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.
Enrollment and Stopping Rules for Managing Toxicity Requiring Long Follow-Up in Phase II Oncology Trials. Read more about Enrollment and Stopping Rules for Managing Toxicity Requiring Long Follow-Up in Phase II Oncology Trials.
The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies. Read more about The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies.
Analysis of the Proportional Hazards Model with Sparse Longitudinal Covariates. Read more about Analysis of the Proportional Hazards Model with Sparse Longitudinal Covariates.
BAYESIAN INFERENCE OF HIDDEN GAMMA WEAR PROCESS MODEL FOR SURVIVAL DATA WITH TIES. Read more about BAYESIAN INFERENCE OF HIDDEN GAMMA WEAR PROCESS MODEL FOR SURVIVAL DATA WITH TIES.
Hypothesis testing for two-stage designs with over or under enrollment. Read more about Hypothesis testing for two-stage designs with over or under enrollment.
A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events. Read more about A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.
Regression analysis of sparse asynchronous longitudinal data. Read more about Regression analysis of sparse asynchronous longitudinal data.
Estimation After a Group Sequential Trial. Read more about Estimation After a Group Sequential Trial.
Statistical inference for the additive hazards model under outcome-dependent sampling. Read more about Statistical inference for the additive hazards model under outcome-dependent sampling.
